Rapport d’évaluation EN

CRCL - Centre de recherche en cancérologie de Lyon

Type : Rapport d’évaluation d’une entité de recherche
Campagne d'évaluation : 2019-2020 (vague A) - Publié le : 16/06/2020
Établissement(s) concerné(s) : Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM , Université Claude Bernard Lyon 1 - UCBL
Domaine(s) disciplinaire(s) de recherche : Sciences de la vie et de la terre (SVE)
Domaine(s) scientifique(s) : 5 - Biologie, medecine et santé
Panel(s) ERC : LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals, LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine, LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics
Nom des équipes de l'unité : Apoptosis, cancer and development ; Tumor surveillance and therapeutic targeting ; Oncopharmacology ; Cancer cell plasticity in melanoma ; Targeting non-canonical protein functions in cancer ; Integrated analysis of the dynamics of cancer ; TGF-beta and immuno-regulation ; Molecular regulation of cancer immunity ; Samme molecules for biological targets ; TGF-beta, tumor plasticity and migration ; Hepatitis viruses and pathobiology of chronic liver diseases ; Epigenetics and epigenomics of hepatocellular carcinoma ; Senescence, cancer and aging ; Cancer cell death ; Inflammasome and cancer ; Ribosome, translation and cancer ; BMP: ecosystem, stemness and dynamic for cancer ; Stemness in Gliomas ; Cellular reprogramming, stem cells and oncogenesis ; Genetics, epigenetics and biology of sarcoma ; Signalling, metabolism and tumor progression ; Cell death and childhood cancers
Mot(s) clé(s) : oncogenèse ; échappement tumoral ; immunologie ; virologie ; thérapeutiques ciblées

Télécharger le fichier